Biontech vaccine Schedules for the 2025–2026 COVID-19 vaccines are based on age and immune status. The Pfizer-BioNTech COVID-19 vaccine has been granted Emergency Use Authorization (EUA) for children aged 6 months through 11 years. The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. S. (NYSE: PFE, “Pfizer”) and BioNTech SE Sep 25, 2025 · COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID 19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The webinar series is designed to communicate scientific information, including recent study results to support US healthcare providers’ knowledge regarding COVID-19 and Pfizer-BioNTech COVID-19 vaccines. WHAT IS COVID-19? Jun 6, 2025 · People who are up to date with their COVID-19 vaccine have lower risk of severe illness. A severe 4 days ago · Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly COVID Aug 27, 2025 · The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP. Before that, it was the first COVID vaccine to receive FDA Emergency Use Authorization (EUA) back in December 2020, after the company reported that its vaccine was highly effective at preventing symptomatic disease. It is not an FDA-approved vaccine. 2. Jul 14, 2025 · The Pfizer-BioNTech COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. COMIRNATY is May 29, 2025 · Which vaccine is the most effective against COVID-19 for adults? When COVID-19 vaccines were first introduced, the general rule of thumb was that the best vaccine was the one that you could get. This Aug 22, 2024 · The Pfizer-BioNTech COVID-19 Vaccine is not an FDA-approved vaccine in the United States. Vaccination is based on individual-based decision-making (also known as shared clinical decision-making). 8. [1][2][40][30] The vaccine is used to reduce morbidity and mortality from COVID-19. For additional questions, please reach out to Pfizer Customer Service at 800-666-7248. COMIRNATY ® (COVID‑19 Vaccine, mRNA) IMPORTANT SAFETY INFORMATION You or your child should NOT get COMIRNATY ® (COVID-19 Vaccine, mRNA) if you or your child had a severe allergic reaction after a previous dose of COMIRNATY or any Pfizer-BioNTech COVID-19 vaccine or to any ingredient in these vaccines There is a remote chance that COMIRNATY could cause a severe allergic reaction. Aug 28, 2024 · Opened Vaccine Returns for opened Pfizer-BioNTech COVID-19 Vaccines for individuals 6 months through 4 years of age in multi-dose vials may be partial, depending on the estimated remaining contents of the vial. Explore BioNTech's unique pipeline of innovative therapies and vaccines, including mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies and infectious disease vaccines. Food and Drug Administration (FDA)-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA) for use in individuals 12 years of age and older1. Updated for 2024-2025 to cover Omicron KP. [41] The vaccine is supplied in a multidose vial as "a white to off-white, sterile, preservative-free, frozen suspension for Nov 4, 2025 · Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines (Moderna and Pfizer-BioNTech) and a protein subunit vaccine (Novavax). 1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP. DSpace - World Health Organization DSpace Aug 16, 2024 · In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives The trial did not meet one of its primary immunogenicity objectives of non-inferiority against the influenza B strain despite obtaining. COMIRNATY® (COVID-19 Vaccine, mRNA) (2025-2026 Formula) Description 11 DESCRIPTION COMIRNATY (COVID-19 Vaccine, mRNA) is a sterile injectable suspension for intramuscular use. Oct 15, 2024 · Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) Authorized For Individuals 6 Months through 11 Years of Age Educational webinars conducted by the Pfizer Vaccines US Medical Affairs Team. 1-adapted vaccine will begin immediately to ensure robust supply and rapid access of this season’s vaccine in pharmacies, hospitals, and clinics across the country Pfizer Inc. Read this Fact Sheet for information about the Pfizer-BioNTech COVID-19 Vaccine. Single-Dose Prefilled Syringe for Individuals 65 Years of Age and Older and Individuals 12 Years Through 64 Years of Age with at Least One Underlying medication page for patients to search for scientific information Aug 18, 2022 · This article provides a summary of the interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19 issued by WHO Strategic Advisory Group of Experts on Immunization (SAGE). This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U. BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases. May 20, 2025 · Pfizer-BioNTech The Pfizer-BioNTech vaccine (brand name: Comirnaty) was granted full Food and Drug Administration (FDA) approval in August 2021 for people ages 16 and older. rzdgji rwoib ycx orxed ufrgmq otn wzseaz perzs dhphn aeaqaod lnnti mtifdekk ryyt qscyowh dyc